Immatics (IMTX) Total Liabilities (2019 - 2025)
Immatics' (IMTX) quarterly Total Liabilities came in at $91.1 million in Q4 2025, down 29.74% year-on-year from $129.6 million in Q4 2024, and down 21.68% quarter-over-quarter from $116.3 million in Q2 2025.
Immatics (IMTX) Total Liabilities (2019 - 2025) Analysis & Trends
Immatics has disclosed Total Liabilities across 7 years of filings, most recently posting $91.1 million for Q4 2025.
- Total Liabilities for Q4 2025 came in at $91.1 million, down 29.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.1 million (down 29.74% YoY), and the FY2025 annual result was $88.4 million, down 31.81% from the prior year.
- Total Liabilities came in at $91.1 million for Q4 2025 at Immatics, down from $116.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $314.5 million in Q4 2023 to a low of $91.1 million in Q4 2025.
- The 5-year median for Total Liabilities is $208.8 million (2023), against an average of $204.9 million.
- Across the five-year window, Total Liabilities soared 50.78% in 2023 and sank 58.79% in 2024, its largest moves.
- Immatics' Total Liabilities stood at $172.3 million in 2021, then increased by 21.1% to $208.6 million in 2022, then surged by 50.78% to $314.5 million in 2023, then tumbled by 58.79% to $129.6 million in 2024, then fell by 29.74% to $91.1 million in 2025.
- The last three Total Liabilities figures came in at $91.1 million (Q4 2025), $116.3 million (Q2 2025), and $129.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 91.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.07 Mn |
| Jun 30, 2025 | 116.28 Mn |
| Dec 31, 2024 | 129.62 Mn |
| Sep 30, 2024 | 217.52 Mn |
| Jun 30, 2024 | 264.59 Mn |
| Mar 31, 2024 | 281.36 Mn |
| Dec 31, 2023 | 314.55 Mn |
| Jun 30, 2023 | 209.05 Mn |
| Dec 31, 2022 | 208.61 Mn |
| Jun 30, 2022 | 259.68 Mn |
| Dec 31, 2021 | 172.26 Mn |
| Jun 30, 2021 | 193.73 Mn |
| Dec 31, 2020 | 199.42 Mn |
| Sep 30, 2020 | 188.50 Mn |
| Dec 31, 2019 | 194.96 Mn |